Updates to the Australian Pharmaceutical Benefits Scheme
22 May 2023
Update
Services Australia has published a release detailing new and amended listings of medications on the Australian Pharmaceutical Benefits Scheme (PBS), effective from 1 May 2023.
Amendments have been made to a range of medications on the PBS, including the following medications:
- Methylphenidate (Ritalin® LA) being amended to allow access for adults with a retrospective diagnosis of ADHD. This includes access to capsules containing methylphenidate hydrochloride 10 mg, 20 mg, 30 mg, 40 mg, 60mg (modified release).
- Naltrexone (Naltrexone GH®) having a reduction in authority level for the treatment of alcohol dependence.
Enquiries regarding new and amended listings can be directed to the PBS at pbs@health.gov.au.
More news & views
22 July 2025
Supporting members through retirement: New resources and initiatives
New resources and initiatives are available to support late career and retired members.
22 July 2025
Meet the College’s first lived and living experience advisers
Sam Farr and Kirsty Rosie step into the College’s first lived and living experience roles.
22 July 2025
Embedding lived experience: Psychiatry’s new way forward
The College’s new Lived and Living Experience Strategy sets a clear direction for aspirational chang...